Dolby Laboratories (NYSE:DLB) Upgraded to "Buy" at Wall Street Zen

Dolby Laboratories logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Dolby Laboratories to “Buy” from “Hold,” though the broader analyst consensus remains “Hold,” with an average price target of $76.67.
  • Dolby beat quarterly estimates, reporting EPS of $1.25 versus $1.20 expected and revenue of $373.54 million; revenue grew 21.7% year over year.
  • The company authorized a $350 million share-repurchase plan, allowing it to buy back up to 7% of its outstanding shares.
  • Five stocks to consider instead of Dolby Laboratories.

Dolby Laboratories (NYSE:DLB - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.

Several other research analysts have also recently weighed in on DLB. Rosenblatt Securities lowered their price objective on Dolby Laboratories from $85.00 to $80.00 and set a "buy" rating on the stock in a research report on Monday, November 16th. Zacks Research upgraded shares of Dolby Laboratories from a "strong sell" rating to a "hold" rating in a research note on Friday, November 13th. Robert W. Baird lowered their price target on shares of Dolby Laboratories from $62.00 to $60.00 and set a "neutral" rating on the stock in a research report on Thursday. Finally, Weiss Ratings raised shares of Dolby Laboratories from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Wednesday, September 9th. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $76.67.

View Our Latest Analysis on Dolby Laboratories

Dolby Laboratories Stock Up 0.8%

Shares of DLB stock opened at $55.22 on Friday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $69.95. The company has a market capitalization of $5.17 billion, a PE ratio of 20.45 and a beta of 0.79. The firm has a 50 day moving average price of $60.46 and a two-hundred day moving average price of $59.29.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its earnings results on Tuesday, November 17th. The electronics maker reported $1.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.20 by $0.05. The company had revenue of $373.54 million for the quarter, compared to analyst estimates of $372.76 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%. The firm's quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.99 earnings per share. Dolby Laboratories has set its Q1 2027 guidance at 0.410-0.560 EPS and its FY 2027 guidance at 4.270-4.420 EPS. As a group, research analysts expect that Dolby Laboratories will post 3.36 EPS for the current year.

Dolby Laboratories declared that its Board of Directors has authorized a stock buyback plan on Thursday, July 30th that authorizes the company to repurchase $350 million in shares. This repurchase authorization authorizes the electronics maker to repurchase up to 7% of its stock through open market purchases. Share repurchase plans are usually a sign that the company's management believes its stock is undervalued.

Insiders Place Their Bets

In related news, SVP John D. Couling sold 7,667 shares of the firm's stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president owned 166,803 shares in the company, valued at approximately $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Ryan Nicholson sold 1,183 shares of the firm's stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the transaction, the chief accounting officer owned 34,453 shares in the company, valued at $2,249,091.84. The trade was a 3.32% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 16,517 shares of company stock valued at $995,963. Corporate insiders own 37.93% of the company's stock.

Institutional Investors Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently bought and sold shares of DLB. Fulcrum Asset Management LLP boosted its position in shares of Dolby Laboratories by 733.7% during the 3rd quarter. Fulcrum Asset Management LLP now owns 1,434 shares of the electronics maker's stock worth $83,000 after acquiring an additional 1,262 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in Dolby Laboratories by 130.1% in the third quarter. Nisa Investment Advisors LLC now owns 1,452 shares of the electronics maker's stock valued at $85,000 after acquiring an additional 821 shares during the last quarter. Nykredit A S acquired a new position in Dolby Laboratories during the second quarter valued at approximately $101,000. Hantz Financial Services Inc. raised its position in Dolby Laboratories by 86.0% during the third quarter. Hantz Financial Services Inc. now owns 2,557 shares of the electronics maker's stock valued at $150,000 after purchasing an additional 1,182 shares in the last quarter. Finally, Greenwich Wealth Management LLC acquired a new position in Dolby Laboratories during the third quarter valued at approximately $217,000. Institutional investors own 58.56% of the company's stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

See Also

Analyst Recommendations for Dolby Laboratories (NYSE:DLB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines